About SmartPill
SmartPill is a Healthcare company based in Buffalo (United States) founded in 2005, and was acquired by Given Imaging in October 2012. SmartPill has raised $9.52 million across 1 funding round from investors including Given Imaging and Oxford Bioscience Partners. Its chief executive, as recorded, is David Barthel. The company was acqui-hired. Its focus areas include Life Sciences, Gastroenterology, Medical Devices and Screening Devices. Its legal entity is SMARTPILL CORPORATION.
Company details
Developer of monitoring device for detecting gastrointestinal disorders. The company has developed SmartPill a capsule-based, gastrointestinal monitoring system for the evaluation of delayed gastric emptying and chronic constipation.
- Headquarters Buffalo, United States
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Website smartpillcorp.com
- Acquired by Given Imaging (Oct 2012)
- Legal Name Smartpill Corporation
- Total Equity Funding$9.52M (USD)
in 1 rounds
- Latest Funding Round$9.52M (USD), Series A
Aug 2010
- InvestorsGiven Imaging
& 1 more
- Acquired byGiven Imaging
(Oct 2012)
Funding Insights of SmartPill
SmartPill has successfully raised a total of $9.52M through 1 strategic funding round. The most recent funding activity was a Series A round of $9.52 million completed in August 2010. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $9.52M
- Total Rounds 1
- Last Round Series A — $9.52M
- First Round $9.52M
(Aug 2010)
- Investors Count 1
All 1 funding rounds of SmartPill with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2010 | $9.52M | Series A | – | Oxford Bioscience Partners | – |
2 investors in total: 2 institutional.
Investors in SmartPill
SmartPill has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Given Imaging and Oxford Bioscience Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Early stage VC firm investing in the US and Korea | oxbio.com | Boston, United States | ||
Capsule endoscopy systems for GI imaging | 1998 | givenimaging.com | Minneapolis, United States |
Investor details for SmartPill
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of SmartPill
1 people are tracked at SmartPill (1 in leadership).
| Name | Role | Group |
|---|---|---|
David Barthel | CEO | Leadership |
Complete people profiles for SmartPill
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of SmartPill
3 dated milestones of SmartPill across 7 years, from founding to its latest funding, stage changes and deals.
- Founded SmartPill is founded.
- Funding First funding round of $9.5M.
- Exit Acquired by Given Imaging.
Top companies in Gastroenterology
3 companies that operate in the same segment as SmartPill (Gastroenterology) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Therapeutics for gastrointestinal disorders, including linaclotide, are developed. | 1998 | Cambridge, Massachusetts, United States | USD 206.25 M | USD 296.15 M | 253 | |
Sacral neuromodulation devices are developed for urinary and bowel control. | 2013 | Irvine, California, United States | USD 143.47 M | |||
Provider of a deep learning platform for detecting circulating cancer-related markers | 2014 | United States | USD 1.35 B | 411 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about SmartPill
SmartPill was founded in 2005 and raised its 1st funding round 5 years after it was founded.
SmartPill is headquartered in Buffalo, United States. It is registered at Buffalo, New York, United States.
David Barthel is the CEO of SmartPill, as recorded in our data.
SmartPill is a funded company, having raised a total of $9.52M across 1 funding round to date. The company's 1st funding round was a Series A of $9.52M, raised on Aug 2010.
Developer of monitoring device for detecting gastrointestinal disorders. The company has developed SmartPill a capsule-based, gastrointestinal monitoring system for the evaluation of delayed gastric emptying and chronic constipation.
SmartPill has 2 investors. Key investors include Given Imaging, and Oxford Bioscience Partners.
SmartPill operates through Smartpill Corporation.
Yes. SmartPill was acquired by Given Imaging in October 2012.